Glabellar Frown Lines (GL) Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Cohort Study to Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines
To evaluate the safety and efficacy of EB-001 compared to placebo in subjects with glabellar frown lines (GL).
This study of EB-001 to measure safety and efficacy in GL. Single doses of EB- 001 administered through IM injection into procerus at midline and the medial and lateral corrugators will be assessed in healthy subjects with glabellar frown lines. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04247074 -
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
|
Phase 3 |